Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.02B | 474.30M | 505.60M | 449.70M | 231.40M |
| Total Depreciation and Amortization | 951.70M | 939.00M | 929.20M | 924.40M | 926.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.10M | 327.50M | 369.30M | 406.40M | 438.30M |
| Change in Net Operating Assets | -396.20M | -503.40M | -453.50M | -425.30M | -311.40M |
| Cash from Operations | 1.58B | 1.24B | 1.35B | 1.36B | 1.28B |
| Capital Expenditure | -602.80M | -590.60M | -560.60M | -482.90M | -446.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -134.90M | -32.90M | -32.90M | -118.70M | -99.80M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.20M | -47.20M | 3.30M | 11.30M | 16.80M |
| Cash from Investing | -778.90M | -670.70M | -590.20M | -590.30M | -529.20M |
| Total Debt Issued | 499.80M | 375.00M | 808.00M | 728.00M | 458.00M |
| Total Debt Repaid | -445.20M | -666.00M | -1.09B | -1.05B | -1.52B |
| Issuance of Common Stock | 101.10M | 96.70M | 94.20M | 73.60M | 78.10M |
| Repurchase of Common Stock | -692.20M | -408.30M | -408.30M | -394.00M | -126.40M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -200.90M | -201.10M | -201.30M | -201.30M | -201.20M |
| Other Financing Activities | -26.10M | -21.80M | -22.10M | -17.40M | 466.40M |
| Cash from Financing | -763.50M | -825.50M | -823.40M | -860.00M | -843.80M |
| Foreign Exchange rate Adjustments | 900.00K | 5.50M | -3.60M | -10.50M | -14.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.10M | -253.30M | -66.60M | -105.60M | -102.80M |